MEDTECHVISION 2022

MODERATOR:
Lily Li, Principal, Northpond Ventures

SPEAKERS:
Archana Dubey, Chief Clinical Officer, AliveCor Inc.
Susan Moon, Senior Vice President of the Customer & Digital Experience Team, Exact Sciences
Maital Rasmussen, Chief Commercial Officer, Octave Bioscience

Venture funding in global diagnostics startups increased >260% in 2021 vs. 2019 fueling a diagnostics renaissance (SV Bank Healthcare Report 2021). Point of care testing has been taken from the clinic and delivered directly to the patient’s door; digital technologies and wearables are enabling increased remote patient monitoring; and AI and machine learning are improving diagnostic solutions. These technologies can reduce resource pressures on hospitals and clinics as well as improve the speed and efficiency of the testing process and results. From COVID to cancer and from in-office to on-demand, this is a new industry and ours for the shaping.

MODERATOR:
Fiona Mack, VP Head of CoLABorator US, Bayer

SPEAKERS:
Natalia Birgisson, MD, Co-Founder & Chief Operating Officer, Flourish Health
Kate Rosenbluth, PhD, Co-Founder & Chief Scientific Officer, Cala Health
Kavita Patel, MD, Venture Partner, New Enterprise Associates (NEA)
Kathleen Bauman, Vice President Product, Pear Therapeutics

The convergence of complex technology advancements in sensored wearables, miniaturization, telecommunications, software and new delivery models is creating a new horizon for disruptive, cost-efficient, healthcare solutions.

Paradigm shifts in medtech are transforming patient care from invasive to non-invasive, intervention to prevention, and hospitals to the home. We see technologies that can expand patient access via telehealth or wearables to more effectively manage chronic disease wherever the patient is located. Further, these novel convergent technologies are creating new definitions of therapeutics eg. bioelectronic medicine or digital platforms to better engage, educate and treat patients.

EXECUTIVE INTERVIEW:
Lisa Earnhardt, Executive Vice President, Medical Devices, Abbott

MODERATOR:
Kate Garrett, Managing Partner, Sonder Capital

MODERATOR:
Megan Zweig, Chief Operating Officer, Rock Health

SPEAKERS:
Jaime Wheeler, Senior Vice President, Global Clinical Affairs, Edwards Lifesciences
Kendal Whitlock, Head of Digital Optimization, RWE Clinical Trials, Walgreens Boots Alliance
Joyce Nortey, Sr. Director, Clinical Operations, Evidation Health
Yarmela Pavlovic, VP Global Regulatory Strategy & Policy, Medtronic

Remote clinical trials bypass the traditional limitations of site geography, improve participant diversity, and address the in-person staffing and data collection challenges that sharply limit the size of trials. They offer the rare value of reducing costs to sponsors while simultaneously improving the patient experience. The diagnostic renaissance and convergent technologies have continued to enable the expansion. However, regulatory guidance and industry standards are lagging. Clearing capturing the value of remote trials, while addressing their challenges will be key to moving remote trials from pandemic-era stop-gap to a new standard for medical device evaluation.